Pharmacological targeting of the NLRP3 inflammasome in pre-clinical models of Parkinson's disease using a potent orally active inhibitor (2015–2017)

Grant type:
The Michael J Fox Foundation for Parkinsons Research
Researchers:
  • NHMRC Professorial Fellow
    School of Biomedical Sciences
    Faculty of Medicine
  • NHMRC Leadership Fellow - Group Lea
    Institute for Molecular Bioscience
  • Honorary Associate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
  • Professor and Associate Dean (Resea
    Faculty of Science
    Professor in Biotechnology
    School of Chemistry and Molecular Biosciences
    Faculty of Science
    Affiliate Professor
    Institute for Molecular Bioscience
Funded by:
The Michael J Fox Foundation for Parkinsons Research